Avinger Announces Participation in Canaccord Genuity 37th Annual Growth Conference
03 août 2017 16h01 HE
|
Avinger Inc
REDWOOD CITY, Calif., Aug. 03, 2017 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that the...
Avinger to Announce Second Quarter 2017 Results on August 8, 2017
26 juil. 2017 16h01 HE
|
Avinger Inc
REDWOOD CITY, Calif., July 26, 2017 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that it will...
Avinger Announces Verified Data of 24-Month Outcomes from the Pivotal VISION Study of Lumivascular Technology for Peripheral Artery Disease
31 mai 2017 12h20 HE
|
Avinger Inc
REDWOOD CITY, Calif., and NEW ORLEANS, May 31, 2017 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced...
Avinger Announces Presentations Showcasing Lumivascular Technology at New Cardiovascular Horizons 18th Annual Conference
25 mai 2017 08h00 HE
|
Avinger Inc
REDWOOD CITY, Calif., May 25, 2017 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced a schedule of...
Avinger Announces First Quarter 2017 Results
04 mai 2017 16h01 HE
|
Avinger Inc
REDWOOD CITY, Calif., May 04, 2017 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR) (the “Company”), a leading developer of innovative treatments for peripheral artery disease (“PAD”), today...
Avinger to Announce First Quarter 2017 Results on May 4, 2017
01 mai 2017 08h00 HE
|
Avinger Inc
REDWOOD CITY, Calif., May 01, 2017 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease (“PAD”), today announced that it will...
Avinger’s Pantheris Named a 2017 Gold Edison Award Winner
24 avr. 2017 16h01 HE
|
Avinger Inc
REDWOOD CITY, Calif. and NEW YORK, April 24, 2017 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), was honored at...
Avinger Provides Strategic Update
10 avr. 2017 16h01 HE
|
Avinger Inc
REDWOOD CITY, Calif., April 10, 2017 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR) (the “Company”), a leading developer of innovative treatments for peripheral artery disease (“PAD”), today...
Avinger Announces Fourth Quarter and Full Year 2016 Results
06 mars 2017 16h01 HE
|
Avinger Inc
REDWOOD CITY, Calif., March 06, 2017 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR) (the “Company”), a leading developer of innovative treatments for peripheral artery disease (“PAD”), today...
Avinger to Present at Upcoming Investor Conferences
22 févr. 2017 16h01 HE
|
Avinger Inc
REDWOOD CITY, Calif., Feb. 22, 2017 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease (“PAD”), today announced that the...